ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

RMD ResMed Inc

211.73
-0.65 (-0.31%)
Jun 14 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 1,113,532
Bid Price
Ask Price
News -
Day High 212.00

Low
132.24

52 Week Range

High
229.97

Day Low 208.63
Company Name Stock Ticker Symbol Market Type
ResMed Inc RMD NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.65 -0.31% 211.73 20:00:00
Open Price Low Price High Price Close Price Prev Close
210.97 208.63 212.00 211.73 212.38
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
15,780 1,113,532 $ 210.88 $ 234,824,412 - 132.24 - 229.97
Last Trade Time Type Quantity Stock Price Currency
19:00:00 208,402 $ 211.73 USD

ResMed (RMD) Options Flow Summary

Overall Flow

Bullish

Net Premium

31k

Calls / Puts

100.00%

Buys / Sells

100.00%

OTM / ITM

100.00%

Sweeps Ratio

0.00%

ResMed Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
31.14B 147.09M - 4.22B 897.56M 6.10 34.70
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

ResMed News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No RMD Message Board. Create One! See More Posts on RMD Message Board See More Message Board Posts

Historical RMD Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week211.46214.54207.05211.27711,5760.270.13%
1 Month219.82220.035204.41210.48825,975-8.09-3.68%
3 Months193.60222.96172.19201.581,035,67818.139.36%
6 Months173.96222.96164.1225191.33993,99637.7721.71%
1 Year216.14229.97132.24174.551,158,383-4.41-2.04%
3 Years221.50301.34132.24203.53760,385-9.77-4.41%
5 Years119.28301.34108.85191.90698,03092.4577.51%

ResMed Description

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.